Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 6,251–6,275 of 7,816 matching trials · page 251 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Disulfiram as a Modulator of Amyloid Precursor Protein-processing NCT03212599 Disulfiram |
NA other |
COMPLETED | 17 | Johannes Gutenberg University Mainz OTHER |
2017-07-24 |
|
Fish Oil and Alpha Lipoic Acid in Treating Alzheimer's Disease NCT00090402 Fish Oil; Lipoic Acid; Fish Oil Placebo; Lipoic Acid Placebo Runs in: United States · 1 site |
PHASE1|PHASE2 other |
COMPLETED | 39 | Oregon Health and Science University OTHER |
2017-07-21 |
|
A Clinical Study to Assess Single and Repeat Doses of a New Medication (GSK933776) in Patients With Alzheimer's Disease NCT00459550 GSK933776; Placebo to match GSK933776 Runs in: Australia; Norway; Sweden · 7 sites |
PHASE1 other |
COMPLETED | 50 | GlaxoSmithKline INDUSTRY |
2017-07-21 |
|
PK, Dose Proportionality, Food Effect And Repeat Dose Study Of Rosiglitazone XR In Healthy Volunteers NCT00733785 Rosiglitazone XR Runs in: Germany · 1 site |
PHASE1 other |
COMPLETED | 60 | GlaxoSmithKline INDUSTRY |
2017-07-21 |
|
A Study of RO7105705 in Healthy Participants and Participants With Mild-to-Moderate Alzheimer's Disease NCT02820896 Placebo; RO7105705 Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 74 | Genentech, Inc. INDUSTRY |
2017-07-21 |
|
Doll Therapy Efficacy for People With Dementia Living in Nursing Homes: a Randomized Single-blind Controlled Trial NCT03224143 Doll Therapy Intervention; active control group (SI) Runs in: Switzerland · 1 site |
NA other |
UNKNOWN | 128 | University of Applied Sciences and Arts of Southern Switzerland OTHER |
2017-07-21 |
|
Validation of a Scale of Well-Being Assessment (SIWA) in Patients With Alzheimer's Disease or a Related Disease. NCT02838563 SIWA Runs in: France · 1 site |
NA other |
TERMINATED | 135 | Hospices Civils de Lyon OTHER |
2017-07-13 |
|
Randomised Trial Ketiapine Olanzapine Fast Sedation Agitated Patients Emergency Ward NCT03216941 Ketamine Runs in: Argentina · 1 site |
PHASE4 other |
COMPLETED | 500 | Universidad Nacional de Rosario OTHER |
2017-07-13 |
|
Strength at Home Couples Program (PTSD-Focused Relationship Enhancement Therapy for Returning Veterans) NCT00827879 Strength at Home Couples Group; Supportive Group Therapy Runs in: United States · 2 sites |
NA other |
COMPLETED | 156 | Boston VA Research Institute, Inc. OTHER |
2017-07-12 |
|
A Study to Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease (ABBY) NCT01343966 MABT5102A; MABT5102A; placebo; placebo Runs in: Canada; France; Germany; Spain; United Kingdom; United States · 92 sites |
PHASE2 other |
COMPLETED | 448 | Genentech, Inc. INDUSTRY |
2017-07-12 |
|
A Study to Evaluate the Impact of MABT5102A on Brain Amyloid Load and Related Biomarkers in Patients With Mild to Moderate Alzheimer's Disease NCT01397578 MABT5102A; MABT5102A; placebo; placebo Runs in: France; Spain; United States · 29 sites |
PHASE2 other |
COMPLETED | 91 | Genentech, Inc. INDUSTRY |
2017-07-12 |
|
Pilot Study of Asynchronous and Synchronous Telepsychiatry for Skilled Nursing Facilities NCT02537093 Psychiatric Consultation Runs in: United States · 2 sites |
NA other |
COMPLETED | 40 | University of California, Davis OTHER |
2017-07-11 |
|
Effect of Nature Based Sounds' Intervention on Agitation and Anxiety of Patients Admitted in Intensive Care Units. NCT03213782 Nature based sounds |
NA other |
COMPLETED | 60 | Maharishi Markendeswar University (Deemed to be University) OTHER |
2017-07-11 |
|
Bridging Study With GSK239512 In Patients With Mild To Moderate Alzheimer's Disease NCT00675090 GSK239512; Placebo Runs in: Australia; Czechia; South Korea; United Kingdom · 8 sites |
PHASE1 other |
COMPLETED | 28 | GlaxoSmithKline INDUSTRY |
2017-07-07 |
|
The Evaluation and Follow-up of Individuals With Memory Disorder NCT00001480 Runs in: United States · 2 sites |
NA other |
COMPLETED | 750 | National Institute of Mental Health (NIMH) NIH |
2017-07-02 |
|
Clinical and Genetic Studies of Familial Presenile Dementia With Neuronal Inclusion Bodies NCT00006176 Runs in: United States · 1 site |
NA other |
COMPLETED | 100 | National Human Genome Research Institute (NHGRI) NIH |
2017-07-02 |
|
Effect of Fluoxetine (Prozac) on Domestic Violence NCT00011765 Fluoxetine Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 104 | National Institute on Alcohol Abuse and Alcoholism (NIAAA) NIH |
2017-07-02 |
|
Effects of an Anti-Inflammatory Drug in Alzheimer's Disease NCT00013650 Cyclophosphamate Runs in: United States · 1 site |
PHASE1 anti-inflammatory |
COMPLETED | 60 | National Institute of Mental Health (NIMH) NIH |
2017-07-02 |
|
Test of A Model of Representational Knowledge Stored in the Human Prefrontal Cortex NCT00024908 Runs in: United States · 1 site |
NA other |
COMPLETED | 949 | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
2017-07-02 |
|
Evaluation of Age- and Alzheimer's Disease-Related Memory Disorder NCT00029120 Runs in: United States · 1 site |
NA other |
COMPLETED | 450 | National Institute of Mental Health (NIMH) NIH |
2017-07-02 |
|
Treatment Study of Frontotemporal Dementia NCT00088751 Runs in: United States · 1 site |
NA other |
COMPLETED | 20 | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
2017-07-02 |
|
Double Blind Trial of DC Polarization in FTD NCT00117858 Anodal DC polarization of left prefrontal cortex Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 20 | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
2017-07-02 |
|
Brain Changes in Adolescents While Imagining and Observing Aggressive Behavior NCT00267891 Runs in: United States · 1 site |
NA other |
COMPLETED | 88 | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
2017-07-02 |
|
Electrical Polarization of the Brain in Corticobasal Syndrome NCT00273897 Phoresor II Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 20 | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
2017-07-02 |
|
Steppin' Up: Positive Youth Development Program NCT00341224 Group-mentoring intervention Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | — | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH |
2017-07-02 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial